 - Participants receiving medications or substances that are inducers of CYP3A4 rifampicin, St. Johns wort, phenytoin, carbamazepine, phenobarbital and dexamethasone or that are metabolizedeliminated by predominantly UGT1A1 pathway or by CYP2B6 and CYP2C8. 